Taylor Wessing advises One Peak as lead investor on Series B financing round in Hygraph
VC and growth experts Dr Norman Röchert and Dr Armin Bartsch, advised lead investor One Peak on all legal aspects of the funding round.
Does a clinical trial render the pharmaceutical formulation used therein public?
METAVERSE FOOD and METAVERSE DRINK as trade marks for goods in the “real world”?
AI software ChatGPT – actually a medical device?
Data Protection Law in Clinical Trials – A European Overview
Taylor Wessing advises Vestas on Project Agreements for Offshore Wind Project Nordseecluster
Taylor Wessing advises Vestas on Offshore Wind Project Nordseecluster
CJEU referral on violations of data protection law on the basis of competition law and on the interpretation of the concept of health data
Work/Life: international employment news update
OLG Celle on the obligations of distributors under Art. 14 MDR when distributing non-compliant medical devices in the context of unfair competition law